Cargando…

Emerging Strategies in 3D Culture Models for Hematological Cancers

In vitro cell cultures are fundamental and necessary tools in cancer research and personalized drug discovery. Currently, most cells are cultured using two-dimensional (2D) methods, and drug testing is mainly performed in animal models. However, new and improved methods that implement three-dimensio...

Descripción completa

Detalles Bibliográficos
Autores principales: Barozzi, Dafne, Scielzo, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378728/
https://www.ncbi.nlm.nih.gov/pubmed/37520775
http://dx.doi.org/10.1097/HS9.0000000000000932
_version_ 1785079839197233152
author Barozzi, Dafne
Scielzo, Cristina
author_facet Barozzi, Dafne
Scielzo, Cristina
author_sort Barozzi, Dafne
collection PubMed
description In vitro cell cultures are fundamental and necessary tools in cancer research and personalized drug discovery. Currently, most cells are cultured using two-dimensional (2D) methods, and drug testing is mainly performed in animal models. However, new and improved methods that implement three-dimensional (3D) cell-culturing techniques provide compelling evidence that more advanced experiments can be performed, yielding valuable new insights. In 3D cell-culture experiments, the cell environment can be manipulated to mimic the complexity and dynamicity of the human tissue microenvironment, possibly leading to more accurate representations of cell-to-cell interactions, tumor biology, and predictions of drug response. The 3D cell cultures can also potentially provide alternative ways to study hematological cancers and are expected to eventually bridge the gap between 2D cell culture and animal models. The present review provides an overview of the complexity of the lymphoid microenvironment and a summary of the currently used 3D models that aim at recreating it for hematological cancer research. We here dissect the differences and challenges between, and potential advantages of, different culture methods and present our vision of the most promising future strategies in the hematological field.
format Online
Article
Text
id pubmed-10378728
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103787282023-07-29 Emerging Strategies in 3D Culture Models for Hematological Cancers Barozzi, Dafne Scielzo, Cristina Hemasphere Review Article In vitro cell cultures are fundamental and necessary tools in cancer research and personalized drug discovery. Currently, most cells are cultured using two-dimensional (2D) methods, and drug testing is mainly performed in animal models. However, new and improved methods that implement three-dimensional (3D) cell-culturing techniques provide compelling evidence that more advanced experiments can be performed, yielding valuable new insights. In 3D cell-culture experiments, the cell environment can be manipulated to mimic the complexity and dynamicity of the human tissue microenvironment, possibly leading to more accurate representations of cell-to-cell interactions, tumor biology, and predictions of drug response. The 3D cell cultures can also potentially provide alternative ways to study hematological cancers and are expected to eventually bridge the gap between 2D cell culture and animal models. The present review provides an overview of the complexity of the lymphoid microenvironment and a summary of the currently used 3D models that aim at recreating it for hematological cancer research. We here dissect the differences and challenges between, and potential advantages of, different culture methods and present our vision of the most promising future strategies in the hematological field. Lippincott Williams & Wilkins 2023-07-27 /pmc/articles/PMC10378728/ /pubmed/37520775 http://dx.doi.org/10.1097/HS9.0000000000000932 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Barozzi, Dafne
Scielzo, Cristina
Emerging Strategies in 3D Culture Models for Hematological Cancers
title Emerging Strategies in 3D Culture Models for Hematological Cancers
title_full Emerging Strategies in 3D Culture Models for Hematological Cancers
title_fullStr Emerging Strategies in 3D Culture Models for Hematological Cancers
title_full_unstemmed Emerging Strategies in 3D Culture Models for Hematological Cancers
title_short Emerging Strategies in 3D Culture Models for Hematological Cancers
title_sort emerging strategies in 3d culture models for hematological cancers
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378728/
https://www.ncbi.nlm.nih.gov/pubmed/37520775
http://dx.doi.org/10.1097/HS9.0000000000000932
work_keys_str_mv AT barozzidafne emergingstrategiesin3dculturemodelsforhematologicalcancers
AT scielzocristina emergingstrategiesin3dculturemodelsforhematologicalcancers